{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35990498", "DateRevised": {"Year": "2022", "Month": "08", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.1021/acsomega.2c01921"], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "7", "Issue": "32", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "16"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Integrating UPLC-HR-MS/MS, Network Pharmacology, and Experimental Validation to Uncover the Mechanisms of Jin'gan Capsules against Breast Cancer.", "Pagination": {"StartPage": "28003", "EndPage": "28015", "MedlinePgn": "28003-28015"}, "Abstract": {"AbstractText": ["In the theory of traditional Chinese medicine (TCM), \"liver-qi\" stagnation and heat-induced toxicity represent the main etiologies of breast cancer. Recently, several TCMs with heat-clearing and detoxification efficacy have shown inhibitory effects on breast cancer. Jin'gan capsules (JGCs), initially approved to treat colds in China, are a heat-clearing and detoxification TCM formula. However, the anticancer activity of JGCs against breast cancer and its underlying mechanisms remain unclear. First, we assessed the antiproliferative activity of JGCs in breast cancer cell lines and evaluated their effects on cell apoptosis and the cell cycle by flow cytometry. Furthermore, we identified the potential bioactive components of JGCs and their corresponding target genes and constructed a bioactive compound-target interaction network by ultra-performance liquid chromatography-high-resolution tandem mass spectrometry (UPLC-HR-MS/MS) and network pharmacology analysis. Finally, the underlying mechanism was investigated through gene function enrichment analysis and experimental validation. We found that JGCs significantly inhibited breast cancer cell growth with IC<sub>50</sub> values of 0.56 \u00b1 0.03, 0.16 \u00b1 0.03, and 0.94 \u00b1 0.09 mg/mL for MDA-MB-231, MDA-MB-468, and MCF-7, respectively. In addition, JGC treatment dramatically induced apoptosis and S phase cell cycle arrest in breast cancer cells. Western blot analysis confirmed that JGCs could regulate the protein levels of apoptosis- and cell cycle-related genes. Utilizing UPLC-HR-MS/MS analysis and network pharmacology, we identified 7 potential bioactive ingredients in JGCs and 116 antibreast cancer targets. Functional enrichment analysis indicated that the antitumor effects of JGCs were strongly associated with apoptosis and the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway. Western blot analysis validated that JGC treatment markedly decreased the expression levels of <i>p</i>-JAK2, <i>p</i>-STAT3, and STAT3. Our findings suggest that JGCs suppress breast cancer cell proliferation and induce cell cycle arrest and apoptosis partly by inhibiting the JAK2/STAT3 signaling pathway, highlighting JGCs as a potential therapeutic candidate against breast cancer."], "CopyrightInformation": "\u00a9 2022 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Qiu", "ForeName": "Jianfei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guiyang Hospital of Guizhou Aviation Industry Group, Guiyang 550025, China."}], "LastName": "Zhang", "ForeName": "Zhiyin", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhao", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wei", "ForeName": "Xuenai", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Song", "ForeName": "Hui", "Initials": "H"}, {"Identifier": ["0000-0002-6150-8890"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Yang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences & Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education & Key Laboratory of Medical Molecular Biology of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H.; Ferlay J.; Siegel R. L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca-Cancer J. Clin. 2021, 71, 209\u2013249. 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Trayes K. P.; Cokenakes S. Breast Cancer Treatment. Am. Fam. Physician 2021, 104, 171\u2013178.", "ArticleIdList": ["34383430"]}, {"Citation": "Wimmer K.; Bolliger M.; Bago-Horvath Z.; Steger G.; Kauer-Dorner D.; Helfgott R.; Gruber C.; Moinfar F.; Mittlb\u00f6ck M.; Fitzal F. Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival. Ann. Surg. Oncol. 2020, 27, 1700\u20131707. 10.1245/s10434-019-08089-x.", "ArticleIdList": ["10.1245/s10434-019-08089-x", "PMC7138765", "31873929"]}, {"Citation": "Kumar P.; Aggarwal R. An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 2016, 293, 247\u2013269. 10.1007/s00404-015-3859-y.", "ArticleIdList": ["10.1007/s00404-015-3859-y", "26341644"]}, {"Citation": "Wu Y.; Cheng C. S.; Li Q.; Chen J. X.; Lv L. L.; Xu J. Y.; Zhang K. Y.; Zheng L. The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review. J. Evidence-Based Complementary Altern. Med. 2021, 2021, 2847466.10.1155/2021/2847466.", "ArticleIdList": ["10.1155/2021/2847466", "PMC8260297", "34257674"]}, {"Citation": "Zhu M.; Lyu Z. Analysis on the clinical profiling of current prominent TCM doctors on treatment of breast cancer. China J. Tradit. Chin. Med. Pharm. 2019, 34, 3162\u20133166."}, {"Citation": "Du J.; Wang L.; Huang X.; Zhang N.; Long Z.; Yang Y.; Zhong F.; Zheng B.; Lan W.; Lin W.; et al. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Phytomedicine 2021, 85, 153551.10.1016/j.phymed.2021.153551.", "ArticleIdList": ["10.1016/j.phymed.2021.153551", "33827043"]}, {"Citation": "Zhao X.; Liu J.; Feng L.; Ge S.; Yang S.; Chen C.; Li X.; Peng L.; Mu Y.; Wang Y.; et al. Anti-angiogenic effects of Qingdu granule on breast cancer through inhibiting NFAT signaling pathway. J. Ethnopharmacol. 2018, 222, 261\u2013269. 10.1016/j.jep.2018.01.013.", "ArticleIdList": ["10.1016/j.jep.2018.01.013", "29337215"]}, {"Citation": "Zheng W.; Han S.; Jiang S.; He X.; Li X.; Ding H.; Cao M.; Li P. Antitumor effects of Xi Huang pills on MDA-MB-231 cells in vitro and in vivo. Mol. Med. Rep. 2018, 18, 2068\u20132078. 10.3892/mmr.2018.9203.", "ArticleIdList": ["10.3892/mmr.2018.9203", "PMC6072179", "29956784"]}, {"Citation": "Li Y.; Li X.; Cuiping C.; Pu R.; Weihua Y. Study on the Anticancer Effect of an Astragaloside- and Chlorogenic Acid-Containing Herbal Medicine (RLT-03) in Breast Cancer. J. Evidence-Based Complementary Altern. Med. 2020, 2020, 1515081.10.1155/2020/1515081.", "ArticleIdList": ["10.1155/2020/1515081", "PMC7305538", "32595723"]}, {"Citation": "Yu J. K.; Yue C. H.; Pan Y. R.; Chiu Y. W.; Liu J. Y.; Lin K. I.; Lee C. J. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition via Down-regulation of EGFR Pathway in MDA-MB-231 cells. Anticancer Res. 2018, 38, 2127\u20132135. 10.21873/anticanres.12453.", "ArticleIdList": ["10.21873/anticanres.12453", "29599331"]}, {"Citation": "Rajaratinam H.; Nafi S.; Mohd Nafi S. N. Andrographolide is an Alternative Treatment to Overcome Resistance in ER-Positive Breast Cancer via Cholesterol Biosynthesis Pathway. Malays. J. Med. Sci. 2019, 26, 6\u201320. 10.21315/mjms2019.26.5.2.", "ArticleIdList": ["10.21315/mjms2019.26.5.2", "PMC6839656", "31728115"]}, {"Citation": "Beesetti S. L.; Jayadev M.; Subhashini G. V.; Mansour L.; Alwasel S.; Harrath A. H. Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers. Open Life Sci. 2019, 14, 462\u2013469. 10.1515/biol-2019-0052.", "ArticleIdList": ["10.1515/biol-2019-0052", "PMC7874781", "33817182"]}, {"Citation": "Liu Z.; Tang Y.; Zhou R.; Shi X.; Zhang H.; Liu T.; Lian Z.; Shi X. Bi-directional solid fermentation products of Trametes robiniophila Murr with Radix Isatidis inhibit proliferation and metastasis of breast cancer cells. J. Chin. Med. Assoc. 2018, 81, 520\u2013530. 10.1016/j.jcma.2017.12.003.", "ArticleIdList": ["10.1016/j.jcma.2017.12.003", "29551488"]}, {"Citation": "Li X. H.; He X. R.; Zhou Y. Y.; Zhao H. Y.; Zheng W. X.; Jiang S. T.; Zhou Q.; Li P. P.; Han S. Y. Taraxacum mongolicum extract induced endoplasmic reticulum stress associated-apoptosis in triple-negative breast cancer cells. J. Ethnopharmacol. 2017, 206, 55\u201364. 10.1016/j.jep.2017.04.025.", "ArticleIdList": ["10.1016/j.jep.2017.04.025", "28461119"]}, {"Citation": "Deng X. X.; Jiao Y. N.; Hao H. F.; Xue D.; Bai C. C.; Han S. Y. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. J. Ethnopharmacol. 2021, 274, 113978.10.1016/j.jep.2021.113978.", "ArticleIdList": ["10.1016/j.jep.2021.113978", "33716082"]}, {"Citation": "Afshar E.; Hashemi-Arabi M.; Salami S.; Peirouvi T.; Pouriran R. Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts. Gene 2019, 702, 46\u201355. 10.1016/j.gene.2019.02.106.", "ArticleIdList": ["10.1016/j.gene.2019.02.106", "30898700"]}, {"Citation": "Hu M.; Varier K. M.; Li Z.; Qin X.; Rao Q.; Song J.; Hu A.; Hang Y.; Yuan C.; Gajendran B.; et al. A natural acylphloroglucinol triggered antiproliferative possessions in HEL cells by impeding STAT3 signaling and attenuating angiogenesis in transgenic zebrafish model. Biomed. Pharmacother. 2021, 141, 111877.10.1016/j.biopha.2021.111877.", "ArticleIdList": ["10.1016/j.biopha.2021.111877", "34323693"]}, {"Citation": "Li Y.; Shi Y.; McCaw L.; Li Y. J.; Zhu F.; Gorczynski R.; Duncan G. S.; Yang B.; Ben-David Y.; Spaner D. E. Microenvironmental interleukin-6 suppresses toll-like receptor signaling in human leukemia cells through miR-17/19A. Blood 2015, 126, 766\u2013778. 10.1182/blood-2014-12-618678.", "ArticleIdList": ["10.1182/blood-2014-12-618678", "26041742"]}, {"Citation": "To N. B.; Nguyen Y. T.; Moon J. Y.; Ediriweera M. K.; Cho S. K. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling. Nutrients 2020, 12, 1663.10.3390/nu12061663.", "ArticleIdList": ["10.3390/nu12061663", "PMC7352840", "32503225"]}, {"Citation": "Chen D.; Ma Y.; Li P.; Liu M.; Fang Y.; Zhang J.; Zhang B.; Hui Y.; Yin Y. Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer. Molecules 2019, 24, 2338.10.3390/molecules24122338.", "ArticleIdList": ["10.3390/molecules24122338", "PMC6631638", "31242627"]}, {"Citation": "Ye H.; Wei J.; Tang K.; Feuers R.; Hong H. Drug Repositioning Through Network Pharmacology. Curr. Top. Med. Chem. 2016, 16, 3646\u20133656. 10.2174/1568026616666160530181328.", "ArticleIdList": ["10.2174/1568026616666160530181328", "27334200"]}, {"Citation": "Yuan H.; Ma Q.; Cui H.; Liu G.; Zhao X.; Li W.; Piao G. How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?. Molecules 2017, 22, 1135.10.3390/molecules22071135.", "ArticleIdList": ["10.3390/molecules22071135", "PMC6152294", "28686181"]}, {"Citation": "Huang J.; Chen F.; Zhong Z.; Tan H. Y.; Wang N.; Liu Y.; Fang X.; Yang T.; Feng Y. Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental Evaluation. Front. Pharmacol. 2020, 11, 414.10.3389/fphar.2020.00414.", "ArticleIdList": ["10.3389/fphar.2020.00414", "PMC7145978", "32308626"]}, {"Citation": "Ma X.; Ning S. Shikimic acid promotes estrogen receptor(ER)-positive breast cancer cells proliferation via activation of NF-\u03baB signaling. Toxicol. Lett. 2019, 312, 65\u201371. 10.1016/j.toxlet.2019.04.030.", "ArticleIdList": ["10.1016/j.toxlet.2019.04.030", "31048002"]}, {"Citation": "Haseeb A.; Ansari M. Y.; Haqqi T. M. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes. J. Orthop. Res. 2017, 35, 311\u2013320. 10.1002/jor.23262.", "ArticleIdList": ["10.1002/jor.23262", "PMC5065736", "27082319"]}, {"Citation": "Liu Y.; Liu Y.; Zhang H. L.; Yu F. F.; Yin X. R.; Zhao Y. F.; Ye F.; Wu X. Q. Amelioratory effect of neoandrographolie on myocardial ischemic-reperfusion injury by its anti-inflammatory and anti-apoptotic activities. Environ. Toxicol. 2021, 36, 2367\u20132379. 10.1002/tox.23350.", "ArticleIdList": ["10.1002/tox.23350", "34397165"]}, {"Citation": "Jeon Y. D.; Lee J. H.; Lee Y. M.; Kim D. K. Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model. Biomed. Pharmacother. 2020, 124, 109847.10.1016/j.biopha.2020.109847.", "ArticleIdList": ["10.1016/j.biopha.2020.109847", "31981944"]}, {"Citation": "Zhao X. L.; Yu L.; Zhang S. D.; Ping K.; Ni H. Y.; Qin X. Y.; Zhao C. J.; Wang W.; Efferth T.; Fu Y. J. Cryptochlorogenic acid attenuates LPS-induced inflammatory response and oxidative stress via upregulation of the Nrf2/HO-1 signaling pathway in RAW 264.7 macrophages. Int. Immunopharmacol. 2020, 83, 106436.10.1016/j.intimp.2020.106436.", "ArticleIdList": ["10.1016/j.intimp.2020.106436", "32234671"]}, {"Citation": "Che D.; Zhao B.; Fan Y.; Han R.; Zhang C.; Qin G.; Adams S.; Jiang H. Eleutheroside B increase tight junction proteins and anti-inflammatory cytokines expression in intestinal porcine jejunum epithelial cells (IPEC-J2). J. Anim. Physiol. Anim. Nutr. 2019, 103, 1174\u20131184. 10.1111/jpn.13087.", "ArticleIdList": ["10.1111/jpn.13087", "30990939"]}, {"Citation": "Weng Z.; Chi Y.; Xie J.; Liu X.; Hu J.; Yang F.; Li L. Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-\u03baB Signaling Pathway Inhibition in Bile Duct-Ligated Mice. Cell. Physiol. Biochem. 2018, 49, 1083\u20131096. 10.1159/000493292.", "ArticleIdList": ["10.1159/000493292", "30196285"]}, {"Citation": "Yu Z.; Yang L.; Deng S.; Liang M. Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress. Eur. J. Pharmacol. 2020, 885, 173399.10.1016/j.ejphar.2020.173399.", "ArticleIdList": ["10.1016/j.ejphar.2020.173399", "32712091"]}, {"Citation": "Liu X.; Zhao W.; Wang W.; Lin S.; Yang L. Puerarin suppresses LPS-induced breast cancer cell migration, invasion and adhesion by blockage NF-\u03baB and Erk pathway. Biomed. Pharmacother. 2017, 92, 429\u2013436. 10.1016/j.biopha.2017.05.102.", "ArticleIdList": ["10.1016/j.biopha.2017.05.102", "28558356"]}, {"Citation": "Hien T. T.; Kim H. G.; Han E. H.; Kang K. W.; Jeong H. G. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Mol. Nutr. Food Res. 2010, 54, 918\u2013928. 10.1002/mnfr.200900146.", "ArticleIdList": ["10.1002/mnfr.200900146", "20077420"]}, {"Citation": "Choi E. J.; Kim G. H. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 2008, 15, 683\u2013690. 10.1016/j.phymed.2008.04.006.", "ArticleIdList": ["10.1016/j.phymed.2008.04.006", "18541420"]}, {"Citation": "Jin S.; Zhang Q. Y.; Kang X. M.; Wang J. X.; Zhao W. H. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 2010, 21, 263\u2013268. 10.1093/annonc/mdp499.", "ArticleIdList": ["10.1093/annonc/mdp499", "19889614"]}, {"Citation": "Bao C.; Namgung H.; Lee J.; Park H. C.; Ko J.; Moon H.; Ko H. W.; Lee H. J. Daidzein suppresses tumor necrosis factor-\u03b1 induced migration and invasion by inhibiting hedgehog/Gli1 signaling in human breast cancer cells. J. Agric. Food Chem. 2014, 62, 3759\u20133767. 10.1021/jf500231t.", "ArticleIdList": ["10.1021/jf500231t", "24724627"]}, {"Citation": "Guo J.; Wang Q.; Zhang Y.; Sun W.; Zhang S.; Li Y.; Wang J.; Bao Y. Functional daidzein enhances the anticancer effect of topotecan and reverses BCRP-mediated drug resistance in breast cancer. Pharmacol. Res. 2019, 147, 104387.10.1016/j.phrs.2019.104387.", "ArticleIdList": ["10.1016/j.phrs.2019.104387", "31408695"]}, {"Citation": "Lee C. H.; Huang C. W.; Chang P. C.; Shiau J. P.; Lin I. P.; Lin M. Y.; Lai C. C.; Chen C. Y. Reactive oxygen species mediate the chemopreventive effects of syringin in breast cancer cells. Phytomedicine 2019, 61, 152844.10.1016/j.phymed.2019.152844.", "ArticleIdList": ["10.1016/j.phymed.2019.152844", "31029906"]}, {"Citation": "Pfisterer P. H.; Rollinger J. M.; Schyschka L.; Rudy A.; Vollmar A. M.; Stuppner H. Neoandrographolide from Andrographis paniculata as a potential natural chemosensitizer. Planta Med. 2010, 76, 1698\u20131700. 10.1055/s-0030-1249876.", "ArticleIdList": ["10.1055/s-0030-1249876", "20446243"]}, {"Citation": "Zhang J.; Sun Y.; Zhong L. Y.; Yu N. N.; Ouyang L.; Fang R. D.; Wang Y.; He Q. Y. Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth. Comput. Struct. Biotechnol. J. 2020, 18, 3936\u20133946. 10.1016/j.csbj.2020.11.033.", "ArticleIdList": ["10.1016/j.csbj.2020.11.033", "PMC7734235", "33335690"]}, {"Citation": "Hsieh M. J.; Chen J. C.; Yang W. E.; Chien S. Y.; Chen M. K.; Lo Y. S.; Hsi Y. T.; Chuang Y. C.; Lin C. C.; Yang S. F. Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-\u03baB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition. Biochem. Pharmacol. 2017, 130, 10\u201320. 10.1016/j.bcp.2017.01.011.", "ArticleIdList": ["10.1016/j.bcp.2017.01.011", "28131848"]}, {"Citation": "Ristim\u00e4ki A.; Sivula A.; Lundin J.; Lundin M.; Salminen T.; Haglund C.; Joensuu H.; Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002, 62, 632\u2013635.", "ArticleIdList": ["11830510"]}, {"Citation": "Larkins T. L.; Nowell M.; Singh S.; Sanford G. L. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006, 6, 181.10.1186/1471-2407-6-181.", "ArticleIdList": ["10.1186/1471-2407-6-181", "PMC1559713", "16831226"]}, {"Citation": "Du Y.; Shi A.; Han B.; Li S.; Wu D.; Jia H.; Zheng C.; Ren L.; Fan Z. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro. Internet J. Oncol. 2014, 44, 1385\u20131393. 10.3892/ijo.2014.2299.", "ArticleIdList": ["10.3892/ijo.2014.2299", "24535190"]}, {"Citation": "Majumder M.; Xin X.; Liu L.; Tutunea-Fatan E.; Rodriguez-Torres M.; Vincent K.; Postovit L. M.; Hess D.; Lala P. K. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis. Stem Cells 2016, 34, 2290\u20132305. 10.1002/stem.2426.", "ArticleIdList": ["10.1002/stem.2426", "27301070"]}, {"Citation": "Hu J.; Guo P.; Zhang Y.; Huang Z.; Chen B. MicroRNA-322 regulates the growth, chemosensitivity, migration and invasion of breast cancer cells by targeting NF-kB1. J. BUON. 2020 Jan-Feb, 25, 152\u2013158.", "ArticleIdList": ["32277626"]}, {"Citation": "Glynn S. A.; Boersma B. J.; Dorsey T. H.; Yi M.; Yfantis H. G.; Ridnour L. A.; Martin D. N.; Switzer C. H.; Hudson R. S.; Wink D. A.; et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J. Clin. Invest. 2010, 120, 3843\u20133854. 10.1172/jci42059.", "ArticleIdList": ["10.1172/jci42059", "PMC2964971", "20978357"]}, {"Citation": "Zhang J.; Lin X.; Wu L.; Huang J. J.; Jiang W. Q.; Kipps T. J.; Zhang S. Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis. Oncogene 2020, 39, 2550\u20132567. 10.1038/s41388-020-1165-z.", "ArticleIdList": ["10.1038/s41388-020-1165-z", "31996785"]}, {"Citation": "Shao F.; Pang X.; Baeg G. H. Targeting the JAK/STAT Signaling Pathway for Breast Cancer. Curr. Med. Chem. 2021, 28, 5137\u20135151. 10.2174/0929867328666201207202012.", "ArticleIdList": ["10.2174/0929867328666201207202012", "33290193"]}, {"Citation": "Jang H.; Ko H.; Song K.; Kim Y. S. A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK-STAT3 Signaling. Biomolecules 2019, 9, 278.10.3390/biom9070278.", "ArticleIdList": ["10.3390/biom9070278", "PMC6681226", "31337063"]}, {"Citation": "Yang B.; Shen J. W.; Zhou D. H.; Zhao Y. P.; Wang W. Q.; Zhu Y.; Zhao H. J. Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer. Nat. Prod. Res. 2019, 33, 477\u2013485. 10.1080/14786419.2017.1396596.", "ArticleIdList": ["10.1080/14786419.2017.1396596", "29086600"]}, {"Citation": "Yang J.; Chen L.; Yan Y.; Qiu J.; Chen J.; Song J.; Rao Q.; Ben-David Y.; Li Y.; Hao X. BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells. Biomed. Pharmacother. 2019, 112, 108603.10.1016/j.biopha.2019.108603.", "ArticleIdList": ["10.1016/j.biopha.2019.108603", "30784914"]}, {"Citation": "Fu S.; Cheng R.; Xiang Z.; Deng Z.; Liu T. Rapid Profiling of Chemical Constituents in Qingfei Paidu Granules Using High Performance Liquid Chromatography Coupled with Q Exactive Mass Spectrometry. Chromatographia 2021, 84, 1035\u20131048. 10.1007/s10337-021-04085-0.", "ArticleIdList": ["10.1007/s10337-021-04085-0", "PMC8435196", "34538876"]}, {"Citation": "Ru J.; Li P.; Wang J.; Zhou W.; Li B.; Huang C.; Li P.; Guo Z.; Tao W.; Yang Y.; et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminf. 2014, 6, 13.10.1186/1758-2946-6-13.", "ArticleIdList": ["10.1186/1758-2946-6-13", "PMC4001360", "24735618"]}, {"Citation": "Chen C. Y. TCM Database@Taiwan: the world\u2019s largest traditional Chinese medicine database for drug screening in silico. PLoS One 2011, 6, e1593910.1371/journal.pone.0015939.", "ArticleIdList": ["10.1371/journal.pone.0015939", "PMC3017089", "21253603"]}, {"Citation": "Xu H. Y.; Zhang Y. Q.; Liu Z. M.; Chen T.; Lv C. Y.; Tang S. H.; Zhang X. B.; Zhang W.; Li Z. Y.; Zhou R. R.; et al. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2019, 47, D976\u2013D982. 10.1093/nar/gky987.", "ArticleIdList": ["10.1093/nar/gky987", "PMC6323948", "30365030"]}, {"Citation": "Wu Y.; Zhang F.; Yang K.; Fang S.; Bu D.; Li H.; Sun L.; Hu H.; Gao K.; Wang W.; et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 2019, 47, D1110\u2013D1117. 10.1093/nar/gky1021.", "ArticleIdList": ["10.1093/nar/gky1021", "PMC6323958", "30380087"]}, {"Citation": "Xu X.; Zhang W.; Huang C.; Li Y.; Yu H.; Wang Y.; Duan J.; Ling Y. A novel chemometric method for the prediction of human oral bioavailability. Int. J. Mol. Sci. 2012, 13, 6964\u20136982. 10.3390/ijms13066964.", "ArticleIdList": ["10.3390/ijms13066964", "PMC3397506", "22837674"]}, {"Citation": "Tao W.; Xu X.; Wang X.; Li B.; Wang Y.; Li Y.; Yang L. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J. Ethnopharmacol. 2013, 145, 1\u201310. 10.1016/j.jep.2012.09.051.", "ArticleIdList": ["10.1016/j.jep.2012.09.051", "23142198"]}, {"Citation": "Szklarczyk D.; Santos A.; von Mering C.; Jensen L. J.; Bork P.; Kuhn M. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016, 44, D380\u2013D384. 10.1093/nar/gkv1277.", "ArticleIdList": ["10.1093/nar/gkv1277", "PMC4702904", "26590256"]}, {"Citation": "Wishart D. S.; Feunang Y. D.; Guo A. C.; Lo E. J.; Marcu A.; Grant J. R.; Sajed T.; Johnson D.; Li C.; Sayeeda Z.; et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018, 46, D1074\u2013D1082. 10.1093/nar/gkx1037.", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Davis A. P.; Grondin C. J.; Johnson R. J.; Sciaky D.; McMorran R.; Wiegers J.; Wiegers T. C.; Mattingly C. J. The Comparative Toxicogenomics Database: update 2019. Nucleic Acids Res. 2019, 47, D948\u2013D954. 10.1093/nar/gky868.", "ArticleIdList": ["10.1093/nar/gky868", "PMC6323936", "30247620"]}, {"Citation": "Li Y. H.; Yu C. Y.; Li X. X.; Zhang P.; Tang J.; Yang Q.; Fu T.; Zhang X.; Cui X.; Tu G.; et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 2018, 46, D1121\u2013D1127. 10.1093/nar/gkx1076.", "ArticleIdList": ["10.1093/nar/gkx1076", "PMC5753365", "29140520"]}, {"Citation": "Pletscher-Frankild S.; Pallej\u00e0 A.; Tsafou K.; Binder J. X.; Jensen L. J. DISEASES: text mining and data integration of disease-gene associations. Methods 2015, 74, 83\u201389. 10.1016/j.ymeth.2014.11.020.", "ArticleIdList": ["10.1016/j.ymeth.2014.11.020", "25484339"]}, {"Citation": "Rappaport N.; Twik M.; Plaschkes I.; Nudel R.; Iny Stein T.; Levitt J.; Gershoni M.; Morrey C. P.; Safran M.; Lancet D. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017, 45, D877\u2013D887. 10.1093/nar/gkw1012.", "ArticleIdList": ["10.1093/nar/gkw1012", "PMC5210521", "27899610"]}, {"Citation": "Shannon P.; Markiel A.; Ozier O.; Baliga N. S.; Wang J. T.; Ramage D.; Amin N.; Schwikowski B.; Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498\u20132504. 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Tripathi S.; Pohl M. O.; Zhou Y.; Rodriguez-Frandsen A.; Wang G.; Stein D. A.; Moulton H. M.; DeJesus P.; Che J.; Mulder L. C.; et al. Meta- and Orthogonal Integration of Influenza \u2033OMICs\u2033 Data Defines a Role for UBR4 in Virus Budding. Cell Host Microbe 2015, 18, 723\u2013735. 10.1016/j.chom.2015.11.002.", "ArticleIdList": ["10.1016/j.chom.2015.11.002", "PMC4829074", "26651948"]}, {"Citation": "Szklarczyk D.; Gable A. L.; Nastou K. C.; Lyon D.; Kirsch R.; Pyysalo S.; Doncheva N. T.; Legeay M.; Fang T.; Bork P.; et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021, 49, D605\u2013D612. 10.1093/nar/gkaa1074.", "ArticleIdList": ["10.1093/nar/gkaa1074", "PMC7779004", "33237311"]}, {"Citation": "Chin C. H.; Chen S. H.; Wu H. H.; Ho C. W.; Ko M. T.; Lin C. Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 2014, 8, S11.10.1186/1752-0509-8-s4-s11.", "ArticleIdList": ["10.1186/1752-0509-8-s4-s11", "PMC4290687", "25521941"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "29"}, {"Year": "2022", "Month": "7", "Day": "25"}, {"Year": "2022", "Month": "8", "Day": "22", "Hour": "3", "Minute": "55"}, {"Year": "2022", "Month": "8", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "8", "Day": "7"}], "PublicationStatus": "epublish", "ArticleIdList": ["35990498", "PMC9386888", "10.1021/acsomega.2c01921"]}}], "PubmedBookArticle": []}